PW
REGN icon

Price Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Price Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$5K Hold
9
– – ﹤0.01% 337
2020
Q2 		$6K Buy
9
+5
+125% +$2.84K ﹤0.01% 229
2020
Q1 		$2K Buy
+4
New +$1.65K ﹤0.01% 251
2018
Q3 		– Sell
-6
Closed -$2K – 382
2018
Q2 		$2K Buy
6
+3
+100% +$938 ﹤0.01% 460
2018
Q1 		$1K Sell
3
-3
-50% -$1.04K ﹤0.01% 347
2017
Q4 		$2K Buy
+6
New +$2.43K ﹤0.01% 315

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Price Wealth's REGN Position: Q3 2020 in Review

Price Wealth held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2020 at 9 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Price Wealth first reported a position in REGN in Q4 2017 and has held it in 6 quarters since. The position peaked at $6K in Q2 2020. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

  • Price Wealth held 9 shares of Regeneron Pharmaceuticals worth $5K as of Q3 2020.
  • Price Wealth left its Regeneron Pharmaceuticals share count unchanged in Q3 2020.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Price Wealth's portfolio in Q3 2020, its #337 holding.
  • Price Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
  • Price Wealth's Regeneron Pharmaceuticals position peaked at $6K in Q2 2020.
  • 907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.